Liminal BioSciences Ownership 2024 | Who Owns Liminal BioSciences Now?
Institutional Ownership
5.93%
Insider Ownership
61.26%
Retail Ownership
32.81%
Institutional Holders
11.00
Liminal BioSciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.55% | - | 14,133 | 14,133 | 100.00% | 53,705,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 3.17% | 0.00% | 9,853 | 9,853 | 100.00% | 34,191,000 | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | 0.16% | 0.00% | 500 | 500 | 100.00% | 1,900,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.15% | - | 475 | 475 | 100.00% | 2,000,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.02% | - | 48 | 48 | 100.00% | 182,000 | Mar 31, 2023 |
| IFP ADVISORS, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,850 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,274 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,135 | -100.00% | - | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -9,869 | -100.00% | - | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -7 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -244 | -100.00% | - | Mar 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -486 | -100.00% | - | Mar 31, 2023 |
Liminal BioSciences's largest institutional shareholder is SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 4.55% of the company's total share outstanding, currently valued at $53.70M. The top 10 institutional shareholders own together 8.06% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ESTABROOK CAPITAL MANAGEMENT | 0.16% | 0.00% | 500 | 500 | 100.00% | 1,900,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 3.17% | 0.00% | 9,853 | 9,853 | 100.00% | 34,191,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.55% | - | 14,133 | 14,133 | 100.00% | 53,705,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.15% | - | 475 | 475 | 100.00% | 2,000,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.02% | - | 48 | 48 | 100.00% | 182,000 | Mar 31, 2023 |
| IFP ADVISORS, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,850 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,274 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,135 | -100.00% | - | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -9,869 | -100.00% | - | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -7 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -244 | -100.00% | - | Mar 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -486 | -100.00% | - | Mar 31, 2023 |
The largest Liminal BioSciences shareholder by % of total assets is ESTABROOK CAPITAL MANAGEMENT. The company owns 500.00 shares of Liminal BioSciences (LMNL), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.55% | - | 14,133 | 14,133 | 100.00% | 53,705,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 3.17% | 0.00% | 9,853 | 9,853 | 100.00% | 34,191,000 | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | 0.16% | 0.00% | 500 | 500 | 100.00% | 1,900,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.15% | - | 475 | 475 | 100.00% | 2,000,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.02% | - | 48 | 48 | 100.00% | 182,000 | Mar 31, 2023 |
| IFP ADVISORS, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -7 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -244 | -100.00% | - | Mar 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -486 | -100.00% | - | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,135 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,274 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,850 | -100.00% | - | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -9,869 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Liminal BioSciences's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 14.13K stocks of LMNL, valued at $53.70M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -9,869 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,850 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,274 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,135 | -100.00% | - | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -486 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -244 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -7 | -100.00% | - | Mar 31, 2023 |
| IFP ADVISORS, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | 0.02% | - | 48 | 48 | 100.00% | 182,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.15% | - | 475 | 475 | 100.00% | 2,000,000 | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | 0.16% | 0.00% | 500 | 500 | 100.00% | 1,900,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 3.17% | 0.00% | 9,853 | 9,853 | 100.00% | 34,191,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.55% | - | 14,133 | 14,133 | 100.00% | 53,705,000 | Mar 31, 2023 |
As of Mar 31 2023, Liminal BioSciences's biggest institutional seller is NATIONAL BANK OF CANADA /FI/. The company sold -9.87K shares of LMNL, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.55% | - | 14,133 | 14,133 | 100.00% | 53,705,000 | Mar 31, 2023 |
| NATIONAL BANK OF CANADA /FI/ | 3.17% | 0.00% | 9,853 | 9,853 | 100.00% | 34,191,000 | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | 0.16% | 0.00% | 500 | 500 | 100.00% | 1,900,000 | Mar 31, 2023 |
| ROYAL BANK OF CANADA | 0.15% | - | 475 | 475 | 100.00% | 2,000,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.02% | - | 48 | 48 | 100.00% | 182,000 | Mar 31, 2023 |
Liminal BioSciences's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 14.13K shares, valued at $53.70M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -9,869 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -3,850 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -2,274 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,135 | -100.00% | - | Mar 31, 2023 |
| ESTABROOK CAPITAL MANAGEMENT | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -486 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -244 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -10 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -7 | -100.00% | - | Mar 31, 2023 |
| IFP ADVISORS, INC | - | - | - | -1 | -100.00% | - | Mar 31, 2023 |
Liminal BioSciences's largest sold out institutional shareholder by shares sold is NATIONAL BANK OF CANADA /FI/, sold -9.87K shares, valued at -, as of undefined.
Liminal BioSciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY CONCORD STREET TRUST | 0.00% | 22,737 | - | - | Feb 29, 2024 |
Liminal BioSciences's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 22.74K shares, compromising 0.00% of its total assets.
Liminal BioSciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 22 | 11 | 37.50% |
| 30 Sep, 22 | 8 | -33.33% |
| 30 Jun, 22 | 12 | - |
| 31 Mar, 22 | 12 | - |
| 31 Dec, 21 | 12 | -20.00% |
| 30 Sep, 21 | 15 | -11.76% |
| 30 Jun, 21 | 17 | 142.86% |
| 31 Mar, 21 | 7 | -41.67% |
| 31 Dec, 20 | 12 | - |
| 30 Sep, 20 | 12 | 20.00% |
| 30 Jun, 20 | 10 | 25.00% |
| 31 Mar, 20 | 8 | -11.11% |
| 31 Dec, 19 | 9 | - |
As of 31 Dec 22, 11 institutions are holding Liminal BioSciences's shares, representing an increase of 37.50% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 22 | 184,096 | -9.44% |
| 30 Sep, 22 | 203,284 | -30.03% |
| 30 Jun, 22 | 290,517 | 35.21% |
| 31 Mar, 22 | 214,868 | -36.40% |
| 31 Dec, 21 | 337,839 | 133.11% |
| 30 Sep, 21 | 144,929 | -15.00% |
| 30 Jun, 21 | 170,510 | 315.74% |
| 31 Mar, 21 | 41,014 | -93.70% |
| 31 Dec, 20 | 650,993 | -79.51% |
| 30 Sep, 20 | 3,177,753 | -5.83% |
| 30 Jun, 20 | 3,374,375 | 1.13% |
| 31 Mar, 20 | 3,336,685 | 0.58% |
| 31 Dec, 19 | 3,317,279 | - |
Liminal BioSciences (LMNL) has 184.10K shares outstanding as of 31 Dec 22, down -9.44% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 22 | 5.93% | 13.83% |
| 30 Sep, 22 | 6.55% | 7.48% |
| 30 Jun, 22 | 9.36% | 19.53% |
| 31 Mar, 22 | 6.92% | 5.76% |
| 31 Dec, 21 | 10.97% | 46.81% |
| 30 Sep, 21 | 4.84% | 14.93% |
| 30 Jun, 21 | 5.69% | 303.53% |
| 31 Mar, 21 | 1.37% | 0.19% |
| 31 Dec, 20 | 26.64% | 0.15% |
| 30 Sep, 20 | 134.70% | 0.65% |
| 30 Jun, 20 | 144.08% | 0.71% |
| 31 Mar, 20 | 142.68% | 0.71% |
| 31 Dec, 19 | 141.82% | - |
As of 31 Dec 22, Liminal BioSciences is held by 5.93% institutional shareholders, representing a 13.83% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 4 | - |
| 30 Sep, 22 | - | -100.00% |
| 30 Jun, 22 | 3 | -50.00% |
| 31 Mar, 22 | 6 | -33.33% |
| 31 Dec, 21 | 9 | 80.00% |
| 30 Sep, 21 | 5 | -44.44% |
| 30 Jun, 21 | 9 | 350.00% |
| 31 Mar, 21 | 2 | -66.67% |
| 31 Dec, 20 | 6 | - |
| 30 Sep, 20 | 6 | - |
| 30 Jun, 20 | 6 | 20.00% |
| 31 Mar, 20 | 5 | -44.44% |
| 31 Dec, 19 | 9 | - |
4 institutional shareholders have increased their position in LMNL stock as of 31 Dec 22 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 4 | 100.00% |
| 30 Sep, 22 | 2 | -50.00% |
| 30 Jun, 22 | 4 | 33.33% |
| 31 Mar, 22 | 3 | 50.00% |
| 31 Dec, 21 | 2 | -33.33% |
| 30 Sep, 21 | 3 | 50.00% |
| 30 Jun, 21 | 2 | - |
| 31 Mar, 21 | 2 | -33.33% |
| 31 Dec, 20 | 3 | -40.00% |
| 30 Sep, 20 | 5 | 400.00% |
| 30 Jun, 20 | 1 | - |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | - | - |
4 institutional shareholders have reduced their position in LMNL stock as of 31 Dec 22 compared to 2 in the previous quarter (a 100.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 22 | 11 | 37.50% | 184,096 | -9.44% | 5.93% | 13.83% | 4 | - | 4 | 100.00% |
| 30 Sep, 22 | 8 | -33.33% | 203,284 | -30.03% | 6.55% | 7.48% | - | -100.00% | 2 | -50.00% |
| 30 Jun, 22 | 12 | - | 290,517 | 35.21% | 9.36% | 19.53% | 3 | -50.00% | 4 | 33.33% |
| 31 Mar, 22 | 12 | - | 214,868 | -36.40% | 6.92% | 5.76% | 6 | -33.33% | 3 | 50.00% |
| 31 Dec, 21 | 12 | -20.00% | 337,839 | 133.11% | 10.97% | 46.81% | 9 | 80.00% | 2 | -33.33% |
| 30 Sep, 21 | 15 | -11.76% | 144,929 | -15.00% | 4.84% | 14.93% | 5 | -44.44% | 3 | 50.00% |
| 30 Jun, 21 | 17 | 142.86% | 170,510 | 315.74% | 5.69% | 303.53% | 9 | 350.00% | 2 | - |
| 31 Mar, 21 | 7 | -41.67% | 41,014 | -93.70% | 1.37% | 0.19% | 2 | -66.67% | 2 | -33.33% |
| 31 Dec, 20 | 12 | - | 650,993 | -79.51% | 26.64% | 0.15% | 6 | - | 3 | -40.00% |
| 30 Sep, 20 | 12 | 20.00% | 3,177,753 | -5.83% | 134.70% | 0.65% | 6 | - | 5 | 400.00% |
| 30 Jun, 20 | 10 | 25.00% | 3,374,375 | 1.13% | 144.08% | 0.71% | 6 | 20.00% | 1 | - |
| 31 Mar, 20 | 8 | -11.11% | 3,336,685 | 0.58% | 142.68% | 0.71% | 5 | -44.44% | 1 | - |
| 31 Dec, 19 | 9 | - | 3,317,279 | - | 141.82% | - | 9 | - | - | - |
Liminal BioSciences Peer Ownership
| Ticker | Company |
|---|---|
| CYT | Cyteir Therapeutics, Inc. |
| XCUR | Exicure, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| XTLB | XTL Biopharmaceuticals Ltd. |
| KTTA | Pasithea Therapeutics Corp. |
| ERAS | Erasca, Inc. |
| SPRB | Spruce Biosciences, Inc. |
| ERYP | PHAXIAM Therapeutics S.A. |
| EYEN | Eyenovia, Inc. |
| RZLT | Rezolute, Inc. |
| SNGX | Soligenix, Inc. |
| TPST | Tempest Therapeutics, Inc. |
| ATXI | Avenue Therapeutics, Inc. |
| ADXN | Addex Therapeutics Ltd |
| PTIX | Protagenic Therapeutics, Inc. |
| IMUX | Immunic, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| FBRX | Forte Biosciences, Inc. |
LMNL Ownership FAQ
Who Owns Liminal BioSciences?
Liminal BioSciences is owned by institutional shareholders (5.93%), insiders (61.26%), and public (32.81%). The largest institutional shareholder of Liminal BioSciences is SUSQUEHANNA INTERNATIONAL GROUP, LLP (4.55% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Liminal BioSciences?
Liminal BioSciences's major institutional shareholders are SUSQUEHANNA INTERNATIONAL GROUP, LLP, NATIONAL BANK OF CANADA /FI/, ESTABROOK CAPITAL MANAGEMENT, ROYAL BANK OF CANADA, and UBS GROUP AG. The top five shareholders own together 8.06% of the company's share outstanding.
How many Liminal BioSciences shareholders are there?
As of Dec 2022, there are 11 institutional shareholders of Liminal BioSciences.
What percentage of Liminal BioSciences is owned by SUSQUEHANNA INTERNATIONAL GROUP, LLP?
SUSQUEHANNA INTERNATIONAL GROUP, LLP owns 14.13K shares of Liminal BioSciences, representing 4.55% of the company's total shares outstanding, valued at $53.7M (as of Mar 2023).
What percentage of Liminal BioSciences is owned by NATIONAL BANK OF CANADA /FI/?
As of Mar 2023, NATIONAL BANK OF CANADA /FI/ holds 9.85K shares of Liminal BioSciences (LMNL), compromising 3.17% of the company, valued at $34.19M.
What percentage of Liminal BioSciences is owned by ESTABROOK CAPITAL MANAGEMENT?
ESTABROOK CAPITAL MANAGEMENT is the third largest holder of Liminal BioSciences. The company owns 500 of the company's shares outstanding (worth $1.9M).